Showing results (71-80 of 471) with videos related to

Sort By:
Pageof 48
Histopathology|October 1, 1990
Comparative phenotypes in rhabdomyosarcomas and developing skeletal muscleR L Carter, C F Jameson, E R Philp, et al.
Archives of Disease in Childhood|May 23, 2001
Response to influenza immunisation during treatment for cancerJ C Chisholm, T Devine, A Charlett, et al.
Lancet (London, England)|November 1, 1980
Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?C R Pinkerton, S G Welshman, J F Glasgow, et al.
Archives of Disease in Childhood|September 1, 1990
How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study GroupJ J Groot-Loonen, C R Pinkerton, P H Morris-Jones, et al.
Archives of Disease in Childhood|August 1, 1990
5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatmentC R Pinkerton, D Williams, C Wootton, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|February 19, 2000
Development of the Royal Marsden Hospital paediatric oncology quality of life questionnaireM Watson, L Edwards, L Von Essen, et al.
Cancer|February 1, 1991
Response rates in relapsed Wilms' tumor. A need for new effective agentsC R Pinkerton, J J Groot-Loonen, P H Morris-Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
21-day schedule oral etoposide in children--a feasibility studyA Davidson, I Lewis, A D Pearson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2007
Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumoursF Pein, R Pinkerton, P Berthaud, et al.
Annales D'Urologie|January 1, 1993
[Has interleukin 2 modified the outcome of metastatic kidney cancer?]S Négrier, T Philip
Pageof 48